Stock GRF GRIFOLS, S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Valuation Grifols, S.A.

Equities

GRF

ES0171996087

Pharmaceuticals

Market Closed - BME
Other stock markets
 11:35:05 2025-01-24 am EST 		5-day change 1st Jan Change
8.616 EUR +1.20% Intraday chart for Grifols, S.A. -3.08% -5.82%
Jan. 24 European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Gains 2% for Week MT
Jan. 23 European Equities Traded in the US as American Depositary Receipts Rise Thursday MT

Company Valuation: Grifols, S.A.

Data adjusted to current consolidation scope
Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 18,760 14,161 9,783 6,557 9,231 5,388 5,388 -
Change - -24.52% -30.92% -32.97% 40.77% -41.63% 0% -
Enterprise Value (EV) 1 25,225 20,597 16,478 15,716 18,568 14,744 14,410 13,809
Change - -18.35% -20% -4.63% 18.15% -20.59% -2.27% -4.17%
P/E ratio 34.5x 26.5x 62.5x 34.7x 172x 26.7x 10.3x 7.82x
PBR 4.46x 1.99x 1.89x 1.19x 1.79x 1.04x 0.97x 0.88x
PEG - -24.12x -0.9x 2.3x -2.4x 0x 0x 0.2x
Capitalization / Revenue 3.68x 2.65x 1.98x 1.08x 1.4x 0.75x 0.7x 0.65x
EV / Revenue 4.95x 3.86x 3.34x 2.59x 2.82x 2.06x 1.86x 1.67x
EV / EBITDA 17.9x 13.9x 17.1x 12.9x 12.8x 8.36x 7.09x 6.14x
EV / EBIT 22.3x 20.7x 27.7x 19.5x 18.1x 11.8x 9.54x 8.09x
EV / FCF 161x 25.7x 52.1x -56.7x -213x 23.5x 24x 16x
FCF Yield 0.62% 3.9% 1.92% -1.76% -0.47% 4.25% 4.17% 6.23%
Dividend per Share 2 0.36 0.17 0.36 - - - 0.1542 0.2751
Rate of return 1.15% 0.71% 2.13% - - - 1.79% 3.19%
EPS 2 0.91 0.9 0.27 0.31 0.09 0.3229 0.8343 1.102
Distribution rate 39.6% 18.9% 133% - - - 18.5% 25%
Net sales 1 5,099 5,340 4,933 6,064 6,592 7,142 7,738 8,274
EBITDA 1 1,407 1,479 961.5 1,221 1,455 1,764 2,031 2,251
EBIT 1 1,131 996.1 595.1 805.7 1,023 1,250 1,511 1,707
Net income 1 625.1 618.5 182.8 208.3 59.32 221.3 575.7 754.2
Net Debt 1 6,465 6,436 6,695 9,158 9,337 9,356 9,022 8,421
Reference price 2 31.430 23.880 16.875 10.770 15.455 8.616 8.616 8.616
Nbr of stocks (in thousands) 684,135 684,540 682,484 678,911 678,665 679,629 679,629 -
Announcement Date 2/27/20 2/26/21 2/28/22 2/28/23 2/28/24 - - -
1EUR in Million2EUR
Estimates

P/E ratio, Detailed evolution

Add to a list
Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 P/E ratio EV / Sales EV / EBITDA Yield Capi. ($)
GRIFOLS, S.A. Stock Grifols, S.A.
26.17x2.06x8.41x-.--%5.59B
CSL LIMITED Stock CSL Limited
26.54x5.8x16.98x+1.75%82.08B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
75.35x16.44x39.85x-.--%52.22B
UCB Stock UCB
64.82x6.09x25.57x+0.76%36.3B
BIOGEN INC. Stock Biogen Inc.
11.27x2.54x7.1x-.--%20.94B
INCYTE CORPORATION Stock Incyte Corporation
188.68x2.72x55.21x-.--%13.97B
INTRA-CELLULAR THERAPIES, INC. Stock Intra-Cellular Therapies, Inc.
-178.83x18.68x-116.24x-.--%13.5B
ALTEOGEN INC. Stock ALTEOGEN Inc.
796.79x218.26x1107.7x - 12.89B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
333.59x - - +0.07%11.87B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
30.83x3.96x19.95x-.--%11.85B
Average 137.52x 30.73x 129.39x +0.29% 26.12B
Weighted average by Cap. 90.59x 19.13x 73.44x +0.69%
See all sector valuations

Income Statement and Estimates

income-statement-evolution-chart GRIFOLS-S-A More financial data

Year-on-year evolution of the PER

evolution-chart GRIFOLS-S-A

Historical PBR trend

evolution-chart GRIFOLS-S-A

Evolution Enterprise Value / Sales

evolution-chart GRIFOLS-S-A

Change in Enterprise Value/EBITDA

evolution-chart GRIFOLS-S-A

Year-on-year evolution of the Yield

evolution-chart GRIFOLS-S-A
  1. Stock Market
  2. Equities
  3. GRF Stock
  4. Valuation Grifols, S.A.